This Mother Jones story is from October 2010 and examines the deadly risks of patients who enroll in pharmaceutical clinical drug trials.
http://motherjones.com/environment/2010/09/dan-markingson-drug-trial-astrazeneca
"The danger lies not just in the particular circumstances that led to Dan's death, but in a system of clinical research that has been thoroughly co-opted by market forces, so that many studies have become little more than covert instruments for promoting drugs. The study in which Dan died starkly illustrates the hazards of market-driven research and the inadequacy of our current oversight system to detect them."
No comments:
Post a Comment